Urinary metabolomics in Fxr-null mice reveals activated adaptive metabolic pathways upon bile acid challenge.

J Lipid Res

Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.

Published: May 2010

Farnesoid X receptor (FXR) is a nuclear receptor that regulates genes involved in synthesis, metabolism, and transport of bile acids and thus plays a major role in maintaining bile acid homeostasis. In this study, metabolomic responses were investigated in urine of wild-type and Fxr-null mice fed cholic acid, an FXR ligand, using ultra-performance liquid chromatography (UPLC) coupled with electrospray time-of-flight mass spectrometry (TOFMS). Multivariate data analysis between wild-type and Fxr-null mice on a cholic acid diet revealed that the most increased ions were metabolites of p-cresol (4-methylphenol), corticosterone, and cholic acid in Fxr-null mice. The structural identities of the above metabolites were confirmed by chemical synthesis and by comparing retention time (RT) and/or tandem mass fragmentation patterns of the urinary metabolites with the authentic standards. Tauro-3alpha,6,7alpha,12alpha-tetrol (3alpha,6,7alpha,12alpha-tetrahydroxy-5beta-cholestan-26-oyltaurine), one of the most increased metabolites in Fxr-null mice on a CA diet, is a marker for efficient hydroxylation of toxic bile acids possibly through induction of Cyp3a11. A cholestatic model induced by lithocholic acid revealed that enhanced expression of Cyp3a11 is the major defense mechanism to detoxify cholestatic bile acids in Fxr-null mice. These results will be useful for identification of biomarkers for cholestasis and for determination of adaptive molecular mechanisms in cholestasis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2853433PMC
http://dx.doi.org/10.1194/jlr.M002923DOI Listing

Publication Analysis

Top Keywords

fxr-null mice
24
bile acids
12
cholic acid
12
bile acid
8
wild-type fxr-null
8
fxr-null
6
mice
6
acid
6
bile
5
urinary metabolomics
4

Similar Publications

Farnesoid X Receptor: Effective alleviation of rifampicin -induced liver injury.

Int Immunopharmacol

September 2024

Key Laboratory of Receptors-Mediated Gene Regulation, School of Basic Medical Sciences, Henan University, Henan, PR China; Key Laboratory of Receptors-Mediated Gene Regulation and Drug Discovery, School of Basic Medical Science, Inner Mongolia Medical University, Hohhot, Inner Mongolia, PR China. Electronic address:

Antituberculosis drugs induce pharmacologic cholestatic liver injury with long-term administration. Liver injury resulting from rifampicin is potentially related to the bile acid nuclear receptor Farnesoid X Receptor (FXR). To investigate this, cholestasis was induced in both wild-type (C57BL/6N) mice and FXR knockout (FXR-null) mice through administration of rifampicin (200 mg/kg) via gavage for 7 consecutive days.

View Article and Find Full Text PDF

Multiomics to Characterize the Molecular Events Underlying Impaired Glucose Tolerance in FXR-Knockout Mice.

J Proteome Res

August 2024

Department of Environmental Sciences and Engineering, University of North Carolina, Chapel Hill, North Carolina 27599, United States.

The prevalence of different metabolic syndromes has grown globally, and the farnesoid X receptor (FXR), a metabolic homeostat for glucose, lipid, and bile acid metabolisms, may serve an important role in the progression of metabolic disorders. Glucose intolerance by FXR deficiency was previously reported and observed in our study, but the underlying biology remained unclear. To investigate the ambiguity, we collected the nontargeted profiles of the fecal metaproteome, serum metabolome, and liver proteome in -null () and wild-type (WT) mice with LC-HRMS.

View Article and Find Full Text PDF

Trimethylamine N-oxide ameliorates hepatic damage including reduction of hepatic bile acids and cholesterol in -null mice.

Int J Food Sci Nutr

June 2024

Department of Food Science and Technology, National Research and Development Agency, Japan Fisheries Research and Education Agency, National Fisheries University, Shimonoseki, Japan.

Article Synopsis
  • - The study investigates the impact of trimethylamine N-oxide (TMAO) on non-alcoholic fatty liver disease (NAFLD) using a special type of mouse that lacks the farnesoid X receptor (FXR).
  • - Mice on a diet enriched with TMAO for 13 weeks showed lower liver damage markers and reduced hepatic bile acid and cholesterol levels compared to regular (wild-type) mice.
  • - The findings indicate that TMAO may improve liver health in FXR-null mice by altering bile acid and cholesterol metabolism without relying on the FXR pathway.
View Article and Find Full Text PDF

The role of FXR and TGR5 in reversing and preventing progression of Western diet-induced hepatic steatosis, inflammation, and fibrosis in mice.

J Biol Chem

November 2022

Department of Biochemistry and Molecular & Cellular Biology, Georgetown University, Washington, District of Columbia, USA. Electronic address:

Article Synopsis
  • * Research on mice fed a Western diet showed that the dual agonist INT-767 significantly reduces liver fat accumulation, inflammation, and fibrosis, while also altering bile acid composition and decreasing liver lipid absorption.
  • * The study indicated that INT-767's effectiveness in mitigating NASH relies on FXR activation, as its benefits were absent in FXR-deficient mice but not in TGR5-deficient models, suggesting specific pathways for treatment.
View Article and Find Full Text PDF

FXR regulates bile acid metabolism, and FXR null (Fxr) mice have elevated bile acid levels and progressive liver injury. The inositol-requiring enzyme 1α/X-box binding protein 1 (XBP1) pathway is a protective unfolded protein response pathway activated in response to endoplasmic reticulum stress. Here, we sought to determine the role of the inositol-requiring enzyme 1α/XBP1 pathway in hepatic bile acid toxicity using the Fxr mouse model.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!